retatrutide trial duration vs. Tirzepatide: What's the Difference? How Long Does Retatrutide Take

While the first GLP-1 medication was approved by the FDA in 2005, this class of medications has drawn new attention in the past few years as more medications have gained approval

These include: A new or persistent lump or swelling in the neck, particularly in the thyroid region Progressive difficulty swallowing (dysphagia) or a sensation of pressure in the throat Persistent hoarseness or voice changes lasting more than three weeks Unexplained stridor (high-pitched breathing sound) Rapidly enlarging neck mass Patients experiencing any of these symptoms should contact their GP promptly for clinical assessment, in line with NICE guidance on suspected cancer referral (NG12)

The biological adaptations that drive weight regain (increased ghrelin, decreased leptin, reduced metabolic rate) are strongest immediately after weight loss

The tirzepatide in Zepbound mimics two hormones, GLP-1 and GIP

Long-term results